Ngā hua rapu - Husain Attarwala
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
TGN1412: From Discovery to Disaster mā Husain Attarwala
I whakaputaina 2010Artigo -
2
Role of antibodies in cancer targeting mā Husain Attarwala
I whakaputaina 2010Artigo -
3
-
4
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) Amyloidosis mā Xiaoping Zhang, Varun Goel, Husain Attarwala, Marianne T. Sweetser, Valerie A. Clausen, Gabriel J. Robbie
I whakaputaina 2019Artigo -
5
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus mā Allison August, Husain Attarwala, Sunny Himansu, Shiva Kalidindi, Sophia Lu, Rolando Pajón, Shu Han, Jean‐Michel Lecerf, Joanne E. Tomassini, Marjie Hard, Leon M. Ptaszek, James E. Crowe, Tal Zaks
I whakaputaina 2021Artigo -
6
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates mā Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal, Qianfan Wang, Krishna Aluri, Xuemei Zhang, Minggeng Gao, Ju Liu, Ramesh Indrakanti, Sally Schofield, Philip Kretschmer, Christopher R. Brown, Swati Gupta, Jennifer L. S. Willoughby, Julie A. Boshar, Vasant Jadhav, Klaus Charissé, Tracy Zimmermann, Kevin Fitzgerald, Muthiah Manoharan, Kallanthottathil G. Rajeev, Akin Akinc, Renta Hutabarat, Martin A. Maier
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Pharmacology
Pharmacodynamics
Pharmacokinetics
Adverse effect
Antibody
Biochemistry
Biology
Chemistry
Gene
Immunology
Alternative medicine
Amyloidosis
Asialoglycoprotein receptor
Cancer
Cancer cell
Cancer research
Cell biology
Chemotherapeutic drugs
Chemotherapy
Chikungunya
Clinical trial
Cognitive science
DNA
Dosing
Drug
Drug delivery
Drug trial
Endocrinology